---
brand_name: "CORDRAN N"
generic_name: "FLURANDRENOLIDE; NEOMYCIN SULFATE"
slug: "flurandrenolide-neomycin-sulfate"
canonical_url: "https://medichelpline.com/drug-index/flurandrenolide-neomycin-sulfate"
content_type: "drug_monograph"
route: "TOPICAL"
drug_class: "General Medications"
license: "Drugs@FDA Public Domain / Informational Use"
---
# CORDRAN N (FLURANDRENOLIDE; NEOMYCIN SULFATE)
## Clinical Monograph Metadata
- **Canonical URL:** https://medichelpline.com/drug-index/flurandrenolide-neomycin-sulfate
- **Generic / Active Ingredient:** FLURANDRENOLIDE; NEOMYCIN SULFATE
- **Brand Name:** CORDRAN N
- **Administration Route:** TOPICAL
- **Pharmacological Class:** General Medications
## Primary Indication & Clinical Use
Marketing status: Discontinued
## Monograph Summary

Approval overview CORDRAN N is listed in Drugs@FDA under application 050345 (NDA). Marketing status: Discontinued Active ingredient FLURANDRENOLIDE; NEOMYCIN SULFATE Form and strength OINTMENT;TOPICAL - 0.05%;EQ 3.5MG BASE/GM Sponsor LILLY Submission history See approval history documents.

## Primary Sources & FDA Regulatory Records
- [Drugs@FDA Primary Database](https://www.accessdata.fda.gov/scripts/cder/daf/) (Reference Slug: `flurandrenolide-neomycin-sulfate`)
## Navigation
- [← Back to Drug Index Hub](https://medichelpline.com/drug-index.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.